Treating hyperglycemia in type 2 diabetes: New goals and strategies

被引:32
作者
Lebovitz, HE [1 ]
机构
[1] SUNY Hlth Sci Ctr, Div Endocrinol & Metab Diabet, Brooklyn, NY 11203 USA
关键词
D O I
10.3949/ccjm.69.10.809
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To achieve glycemic goals in type 2 diabetes, one must usually use combinations of oral agents or oral agents plus insulin. This paper discusses the metabolic derangements of type 2 diabetes, the different classes of anti hyperglycemic drugs, and strategies for using these drugs rationally.
引用
收藏
页码:809 / 820
页数:12
相关论文
共 71 条
[1]   Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes: VA feasibility study on glycemic control and complications (VA CSDM) [J].
Abraira, C ;
Henderson, WG ;
Colwell, JA ;
Nuttall, FQ ;
Comstock, JP ;
Emanuele, NV ;
Levin, SR ;
Sawin, CT ;
Silbert, CK .
DIABETES CARE, 1998, 21 (04) :574-579
[2]   Activators of peroxisome proliferator-activated receptor γ have depot-specific effects on human preadipocyte differentiation [J].
Adams, M ;
Montague, CT ;
Prins, JB ;
Holder, JC ;
Smith, SA ;
Sanders, L ;
Digby, JE ;
Sewter, CP ;
Lazar, MA ;
Chatterjee, VKK ;
O'Rahilly, S .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (12) :3149-3153
[3]   Of mice and men:: KATP channels and insulin secretion [J].
Aguilar-Bryan, L ;
Bryan, J ;
Nakazaki, M .
RECENT PROGRESS IN HORMONE RESEARCH, VOL 56, 2001, 56 :47-68
[4]   Diabetic retinopathy [J].
Aiello, LP ;
Gardner, TW ;
King, GL ;
Blankenship, G ;
Cavallerano, JD ;
Ferris, FL ;
Klein, R .
DIABETES CARE, 1998, 21 (01) :143-156
[5]  
Amos AF, 1997, DIABETIC MED, V14, pS7, DOI 10.1002/(SICI)1096-9136(199712)14:5+<S7::AID-DIA522>3.3.CO
[6]  
2-I
[7]  
[Anonymous], 1995, Diabetes, V44, P1249
[8]  
[Anonymous], 1996, DIABETES, V45, P1289
[9]  
[Anonymous], 1995, Diabetes in America
[10]   Mechanisms of the glycaemic effects of sulfonylureas [J].
Ashcroft, FM .
HORMONE AND METABOLIC RESEARCH, 1996, 28 (09) :456-463